2-86951349-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_001382344.1(RGPD1):c.126T>A(p.Asp42Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001382344.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RGPD1 | NM_001382344.1 | c.126T>A | p.Asp42Glu | missense_variant | Exon 2 of 23 | ENST00000641458.2 | NP_001369273.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RGPD1 | ENST00000641458.2 | c.126T>A | p.Asp42Glu | missense_variant | Exon 2 of 23 | NM_001382344.1 | ENSP00000492954.1 | |||
RGPD1 | ENST00000398193.8 | c.126T>A | p.Asp42Glu | missense_variant | Exon 2 of 23 | 1 | ENSP00000381253.3 | |||
RGPD1 | ENST00000641339.1 | n.*269T>A | non_coding_transcript_exon_variant | Exon 4 of 5 | ENSP00000492933.1 | |||||
RGPD1 | ENST00000641339.1 | n.*269T>A | 3_prime_UTR_variant | Exon 4 of 5 | ENSP00000492933.1 |
Frequencies
GnomAD3 genomes Cov.: 6
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000207 AC: 1AN: 482926Hom.: 0 Cov.: 6 AF XY: 0.00000407 AC XY: 1AN XY: 245538
GnomAD4 genome Cov.: 6
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.102T>A (p.D34E) alteration is located in exon 2 (coding exon 2) of the RGPD1 gene. This alteration results from a T to A substitution at nucleotide position 102, causing the aspartic acid (D) at amino acid position 34 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at